title: New onset of rheumatoid vasculitis during abatacept therapy and subsequent improvement after rituximab.
authors.affiliation: Hôpital de la Cavale Blanche, Service de Rhumatologie, BP 824, 29609 Brest cedex, France; Université de Brest, and Labex "IGO", Laboratoire d'Immunothérapies et Pathologies lymphocytaires B, EA2216, Inserm ESPRI, ERI29, 29609 Brest, France.
authors.forename: Guillermo
authors.initials: G
authors.lastname: Carvajal Alegria
authors.affiliation: CHRU de Brest, Université de Brest, Hôpital Morvan, Service d'Anatomie Pathologique et Cytologie, EA 4685 LNB, 29609 Brest, France.
authors.forename: Arnaud
authors.initials: A
authors.lastname: Uguen
authors.affiliation: CHRU de Brest, Hôpital de la Cavale Blanche, Service d'Explorations Fonctionnelles Neurologiques, 29609 Brest, France.
authors.forename: Steeve
authors.initials: S
authors.lastname: Genestet
authors.affiliation: CHRU de Brest, Université de Brest, Hôpital Morvan, Service d'Anatomie Pathologique et Cytologie, EA 4685 LNB, 29609 Brest, France.
authors.forename: Pascale
authors.initials: P
authors.lastname: Marcorelles
authors.affiliation: Hôpital de la Cavale Blanche, Service de Rhumatologie, BP 824, 29609 Brest cedex, France; Université de Brest, and Labex "IGO", Laboratoire d'Immunothérapies et Pathologies lymphocytaires B, EA2216, Inserm ESPRI, ERI29, 29609 Brest, France.
authors.forename: Alain
authors.initials: A
authors.lastname: Saraux
authors.affiliation: Hôpital de la Cavale Blanche, Service de Rhumatologie, BP 824, 29609 Brest cedex, France; Université de Brest, and Labex "IGO", Laboratoire d'Immunothérapies et Pathologies lymphocytaires B, EA2216, Inserm ESPRI, ERI29, 29609 Brest, France. Electronic address: divi.cornec@chu-brest.fr.
authors.forename: Divi
authors.initials: D
authors.lastname: Cornec
mesh_terms: D000069594:Abatacept / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D056653:Rheumatoid Vasculitis / Q000139:chemically induced* / Q000188:drug therapy*; D000069283:Rituximab / Q000627:therapeutic use*
chemical_list: D018501:Antirheumatic Agents; D000069283:Rituximab; D000069594:Abatacept
keywords: Abatacept; Rheumatoid arthritis; Rheumatoid vasculitis; Rituximab